{
    "clinical_study": {
        "@rank": "50417", 
        "arm_group": {
            "arm_group_label": "Acromegaly", 
            "description": "Patients with acromegaly who have received surgical treatment"
        }, 
        "biospec_descr": {
            "textblock": "blood samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Acromegaly is frequently associated with impaired glucose tolerance and diabetes. We\n      hypothesise that pituitary histopathology and plasma hyperprolactinaemia could have\n      prognostic value in predicting the risk of glucose metabolic disturbances in acromegalic\n      patients. The aim of this study is to examine glucose metabolic outcome in acromegalic\n      patients with and without histologically verified prolactin and growth hormone (GH)\n      co-secreting adenomas. The study population include 79 patients who have all undergone\n      surgical treatment for acromegaly."
        }, 
        "brief_title": "Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acromegaly", 
            "Surgery"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acromegaly", 
                "Hyperprolactinemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Acromegaly is frequently associated with impaired glucose tolerance and diabetes. We\n      hypothesise that pituitary histopathology and plasma hyperprolactinaemia could have\n      prognostic value in predicting the risk of glucose metabolic disturbances in acromegalic\n      patients. The aim of this study is to examine glucose metabolic outcome in acromegalic\n      patients with and without histologically verified prolactin and growth hormone (GH)\n      co-secreting adenomas. 79 patients who have all undergone surgical treatment for acromegaly\n      are included. Clinical and biochemical baseline data are collected from medical records.\n      Patients are divided into two groups based on histopathological evaluation of pituitary\n      adenomas;\n\n        1. pure GH secreting adenomas or\n\n        2. GH and prolactin co-secreting adenomas."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of acromegaly, and treated at the department of Endocrinology, Copenhagen\n             University Hospital, Rigshospitalet, Denmark (tertiary referral hospital), surgical\n             treatment of acromegaly\n\n        Exclusion Criteria:\n\n          -  no surgical treatment performed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with acromegaly treated with surgery"
            }
        }, 
        "enrollment": {
            "#text": "79", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02092129", 
            "org_study_id": "PROL-BG-ACRO"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Acromegaly, surgery, histopathology, hyperprolactinaemia,", 
        "lastchanged_date": "March 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "DK-2100"
                }, 
                "name": "National University Hospital, Department of Medical Endocrinology"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prognostic Value of Pituitary Histopathology and Plasma Hyperprolactinaemia in Predicting the Risk of Glucose Metabolic Disturbances in Patients With Acromegaly.", 
        "overall_official": {
            "affiliation": "Rigshospitalet, Denmark", 
            "last_name": "Ulla Feldt-Rasmussen, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients are grouped according to histopathological evaluation of pituitary adenomas\npure GH secreting adenomas or\nGH and prolactin co-secreting adenomas.", 
            "measure": "Evaluate glucose metabolic outcome related to pituitary histopathology and plasma hyperprolactinaemia in patients with acromegaly", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02092129"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Ulla Feldt-Rasmussen", 
            "investigator_title": "Professor, Chief Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}